Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)
Johnson & Johnson (JNJ) recorded Share-based Compensation of $458 million in Q2 2026, up 11.7% from $410 million a year earlier and up 52.7% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026) Analysis & Trends
On a TTM basis, Johnson & Johnson's Share-based Compensation came in at $1.41 billion as of Jun 28, 2026, up 14.9% year-over-year; for FY2025, it was $1.35 billion, up 15.1% from FY2024.
- Annual Share-based Compensation has increased for three straight years, with a four-year compound annual growth rate of 7.7% (FY2021 to FY2025).
- Across earlier years, Share-based Compensation came in at $1.18 billion in FY2024 (+1.2%), $1.16 billion in FY2023 (+2.1%), $1.14 billion in FY2022 and $1.01 billion in FY2021.
- The Q2 2026 figure is the highest quarterly Share-based Compensation in data going back to Q4 2011.
- On a year-over-year basis, Share-based Compensation has increased for five consecutive quarters, with growth averaging 14.0% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 33.7% in Q4 2024, against a decline of 18.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $300 million (Q1 2026), $309 million (Q4 2025) and $347 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 458.00 Mn |
| Mar 29, 2026 | 300.00 Mn |
| Dec 28, 2025 | 309.00 Mn |
| Sep 28, 2025 | 347.00 Mn |
| Jun 29, 2025 | 410.00 Mn |
| Mar 30, 2025 | 288.00 Mn |
| Dec 29, 2024 | 238.00 Mn |
| Sep 29, 2024 | 295.00 Mn |
| Jun 30, 2024 | 341.00 Mn |
| Mar 31, 2024 | 302.00 Mn |
| Dec 31, 2023 | 178.00 Mn |
| Oct 1, 2023 | 296.00 Mn |
| Jul 2, 2023 | 382.00 Mn |
| Apr 2, 2023 | 306.00 Mn |
| Jan 1, 2023 | 218.00 Mn |
| Apr 3, 2022 | 278.00 Mn |
| Oct 3, 2021 | 259.00 Mn |
| Jul 4, 2021 | 354.00 Mn |
| Apr 4, 2021 | 307.00 Mn |
| Jan 3, 2021 | 160.00 Mn |
API Access
Johnson & Johnson Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();